Linklaters supported Gavi, the Vaccine Alliance behind the global COVAX Covid-19 vaccination initiative.
The transaction concerned a risk management solution from the U.S. International Development Finance Corporation (DFC), in conjunction with Citi, to mitigate risk and overcome financial hurdles with governments that are funding COVID-19 vaccine purchases through the COVAX Facility.
DFC support will help Gavi’s efforts to pre-purchase a target of up to two billion vaccine doses directly from manufacturers and allocate these vaccines rapidly and equitably throughout the world. The solution will offer protection against political risks in nine self-financing countries – across Latin and Central America, the Middle East, and Eastern Europe – participating in COVAX, covering a total amount of more than $383 million in insurance, and exemplifies the collective and global action required to address and end the COVID-19 pandemic.
Linklaters’ cross-practice team on this risk management solution was led by partners Andrew Jones (Picture), Aisling Zarraga and Adam Fogarty with managing associate Kwaku Osei, and was supported by partners Marly Didizian and Savi Hebbur, with managing associates Alistair Fraser and Ben Hagyard, and associates Brittany Sutherland, Adam Barr, and Deborah Soh.
Involved fees earner: Adam Barr – Linklaters; Marly Didizian – Linklaters; Adam Fogarty – Linklaters; Alistair Fraser – Linklaters; Benjamin Hagyard – Linklaters; Savi Hebbur – Linklaters; Andrew Jones – Linklaters; Kwaku Osei – Linklaters; Deborah Soh – Linklaters;
Law Firms: Linklaters;